Nano-Signature Discovery Could Revolutionize Cancer Diagnosis
The new technology has proved to be up to 90% accurate in tests involving 200 human cancer samples and normal DNA.
Read More
Search Results for: prostate cancer
Qiagen Expands NGS Portfolio with Oncology and Immunooncology Panels
The research panels can be performed using Qiagen’s GeneReader NGS system and other platforms, providing deep analysis of disease-related genomic mutations.
Read More
Protagen and German National Center for Tumor Diseases, Heidelberg, to Investigate Immunocompetence of Cancer Patients
Protagen has extended its collaboration with the National Center for Tumor Diseases, Heidelberg, to investigate the immunocompetence of urothelial cancer patients receiving immunotherapy.
Read More
Blood Test May Identify Cancer Patients Who Respond to PSMA-Targeted Therapies
With further validation, the liquid biopsy test could be used to match metastatic prostate cancer patients to suitable therapies.
Read More
Inside Track: Making Inroads with Digital Pathology
Advanced tools and new analytical approaches promise to alter the shape of diagnostic medicine forever.
Read More